background
acut
respiratori
infect
princip
caus
ill
mortal
especi
young
children
worldwid
object
studi
epidemiolog
season
viral
respiratori
infect
hospit
children
age
septemb
august
studi
design
nasopharyng
swab
aspir
collect
symptomat
patient
screen
routin
multiplex
pcr
assay
result
respiratori
virus
detect
children
studi
popul
posit
two
virus
posit
three
posit
four
viral
profil
vari
age
virus
significantli
frequent
children
age
month
human
respiratori
syncyti
viru
p
wherea
other
significantli
frequent
children
age
influenza
virus
p
adenovirus
p
distribut
virus
variabl
year
depend
speci
howev
atmospher
temperatur
rare
found
limit
factor
circul
respiratori
virus
conclus
result
constitut
detail
descript
distribut
respiratori
virus
among
hospit
children
four
consecut
year
data
notabl
highlight
persist
nonenvelop
virus
envelop
virus
throughout
yearregardless
temperatur
variat
recent
year
develop
multiplex
molecular
biolog
techniqu
enabl
rapid
detect
respiratori
virus
mani
differ
context
inde
rapid
identif
respiratori
pathogen
modifi
improv
prevent
cur
manag
patient
clearli
shown
rapid
accur
identif
respiratori
specimen
signific
impact
diseas
progress
enabl
introduct
appropri
therapi
decreas
unnecessari
use
antimicrobi
agent
thu
limit
risk
secondari
infect
medic
establish
multiplex
techniqu
supplant
tradit
method
diagnosi
respiratori
tract
infect
cultur
direct
fluorescentantibodi
stain
enzym
immunoassay
superior
term
sensit
execut
time
turnaround
time
lastli
multiplex
molecular
biolog
techniqu
also
rapidli
adapt
detect
new
emerg
virus
although
reagent
cost
inher
higher
mani
studi
clearli
demonstr
appropri
prescrib
respiratori
multiplex
assay
costeffect
gener
signific
save
hospit
diagnost
spectrum
vari
one
commerci
kit
anoth
although
kit
detect
main
pathogen
influenzaviru
infa
influenzaviru
b
infb
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
enteroviru
ev
human
rhinoviru
hrv
parainfluenzavirus
piv
adenovirus
adv
human
bocaviru
hbov
human
coronavirus
hcov
reason
use
multiplex
molecular
assay
increas
detect
viral
respiratori
infect
coinfect
although
earlier
estim
viral
coinfect
base
cultur
serolog
certain
molecular
method
yield
frequenc
around
determin
pcr
assay
primari
object
present
studi
assess
epidemiolog
season
viral
respiratori
infect
hospit
children
context
analys
result
routin
multiplex
pcr
assay
xtag
respiratori
viral
panel
fast
assay
luminex
molecular
diagnost
respiratori
virus
gather
four
consecut
year
septemb
august
thu
investig
season
yeartoyear
preval
virus
commonli
respons
respiratori
infect
coinfect
perform
singlecentr
retrospect
studi
children
age
admit
amien
univers
hospit
amien
franc
acut
respiratori
ill
accord
local
guidelin
multiplex
pcr
assay
respiratori
virus
use
screen
nasopharyng
swab
aspir
time
respiratori
symptom
sampl
collect
patient
septemb
august
specimen
store
test
nasopharyng
swab
aspir
extract
use
nuclisen
easymag
techniqu
craponn
franc
extract
intern
posit
control
escherichia
coli
phage
provid
manufactur
ad
sampl
extract
screen
xtag
respiratori
viral
panel
fast
assay
luminex
molecular
diagnost
inc
toronto
canada
accord
manufactur
instruct
aliquot
extract
store
posit
run
control
bacteriophag
lambda
dna
use
run
monitor
assay
perform
result
median
fluoresc
intens
mfi
analys
luminex
system
tda
rvp
fast
softwar
version
luminex
assay
detect
differ
respiratori
virus
infa
infb
hrsv
hmpv
evhrv
piv
type
adv
hbov
hcov
retrospect
temperatur
data
obtain
franc
french
state
meteorolog
offic
http
wwwmeteofrancecom
nonparametr
mannwhitney
test
appli
continu
variabl
chisquar
test
fisher
exact
test
appli
categor
variabl
threshold
statist
signific
twotail
set
p
consid
perform
nonintervent
studi
addit
diagnost
monitor
treatment
procedur
appli
routin
patient
care
data
analys
anonym
line
french
legisl
clinic
studi
type
trial
requir
approv
independ
ethic
committe
provis
inform
consent
particip
total
sampl
receiv
septemb
august
analys
neg
respiratori
virus
wherea
posit
least
one
respiratori
viru
total
number
posit
sampl
follow
infa
infb
piv
hrsv
er
hrv
adv
hbov
hcov
hmpv
shown
tabl
viral
profil
vari
age
virus
significantli
frequent
children
age
month
hrsv
p
wherea
other
significantli
frequent
children
age
infainfb
p
adv
p
respect
frequenc
virus
hcov
hmpv
piv
erhrv
vari
patient
age
multiplex
molecular
assay
valuabl
enabl
simultan
detect
sever
differ
virus
sampl
therefor
reveal
presenc
coinfect
sampl
posit
two
differ
virus
posit
three
posit
four
percentag
patient
coinfect
differ
significantli
function
age
p
children
younger
month
children
age
month
children
age
month
viral
profil
coinfect
fig
highlight
predomin
evhrv
inde
evhrv
found
coinfect
two
virus
coinfect
three
virus
infect
four
virus
virus
frequent
detect
evhrv
piv
type
follow
hrsv
adv
hbov
hcov
hmpv
absenc
evhrv
frequent
observ
associ
hrsv
hcov
convers
associ
never
observ
eg
infb
hrsv
piv
hcov
infa
hmpv
retrospect
studi
perform
consecut
year
septemb
august
make
possibl
studi
season
yeartoyear
distribut
variou
virus
region
ocean
temper
climat
unsurprisingli
northern
hemispher
number
assay
perform
higher
winter
summer
tabl
percentag
posit
assay
highest
autumn
mid
septemb
mid
decemb
follow
winter
mid
decemb
mid
march
spring
mid
march
mid
june
summer
mid
june
mid
decemb
number
viral
coinfect
highest
winter
follow
spring
autumn
summer
furthermor
season
distribut
profil
vari
speci
other
shown
fig
ev
hrv
predomin
throughout
year
similarli
adv
link
particular
season
isol
throughout
year
contrast
hrsv
preferenti
infect
children
winter
despit
higher
number
posit
assay
novemb
year
although
frequenc
influenza
virus
rel
low
studi
popul
highest
valu
observ
coldest
month
januari
march
adenovirus
hmpv
hcov
hbov
less
frequent
detect
human
coronavirus
mainli
observ
octob
april
hmpv
rare
predominantli
detect
winter
hbov
distribut
broadli
februari
may
parainfluenzavirus
could
detect
throughout
year
observ
children
winter
howev
temperatur
rare
limit
factor
circul
respiratori
virus
indic
tabl
frequenc
influenza
virus
appear
significantli
associ
temperatur
p
applic
new
multiplex
pcr
assay
provid
new
insight
epidemiolog
viral
respiratori
infect
children
adult
howev
situat
yet
character
inde
result
retrospect
studi
carri
consecut
year
hospit
children
age
show
sampl
posit
least
one
respiratori
viru
agre
report
tanner
et
al
probabl
respiratori
virus
yet
discov
taken
account
via
develop
new
screen
assay
henc
view
increas
proport
lower
upper
respiratori
tract
infect
etiolog
diagnosi
import
expand
syndrom
respiratori
approach
includ
pathogen
present
result
emphas
great
variat
posit
rate
viral
distribut
one
age
group
anoth
confirm
previou
observ
made
franc
wherebi
young
children
age
month
lower
posit
viral
coinfect
rate
older
children
howev
picornavirus
evshrv
frequent
age
group
distribut
vari
greatli
age
children
month
age
month
second
third
frequent
detect
virus
hrsv
piv
respect
rank
differ
children
age
month
inf
virus
frequent
hrsv
second
frequent
type
high
frequenc
hrsv
infect
infant
age
month
age
clearli
document
sever
studi
present
result
confirm
import
screen
hrsv
young
children
howev
high
proport
picornavirus
isol
alon
coinfect
symptomat
children
rais
question
true
pathogen
studi
therefor
requir
lastli
impact
season
temperatur
chang
circul
respiratori
virus
appear
moder
inde
nonenvelop
virus
influenc
higher
temperatur
surviv
deviat
howev
envelop
virus
influenza
viru
appear
restrict
temperatur
possibl
increas
atmospher
temperatur
associ
global
warm
may
modifi
viral
distribut
profileespeci
nonenvelop
virus
conclus
present
studi
provid
broad
descript
distribut
respiratori
virus
among
hospit
children
four
consecut
year
result
highlight
persist
nonenvelop
virus
certain
envelop
virus
throughout
yearregardless
temperatur
variat
may
caus
respiratori
damag
author
taken
part
studi
declar
disclos
regard
fund
conflict
interest
respect
manuscript
